Breast and Cervical Cancer

Share

Mammograms save lives. But, even today, too many women don't have access to lifesaving breast and cervical cancer screenings.

We are working in Congress and in every state legislature to ensure funding for the federal cancer screening and early detection program that has already helped millions of women and saved thousands of lives.

More than 40,000 women will die from breast cancer this year, while over 13,000 will be diagnosed with cervical cancer.  We're working to convince Congress to increase funding for breast and cervical cancer research that could lead to new medical breakthroughs and save more lives.

Take Action

Volunteer with a pink had participating in Lobby Day

Mammograms save lives! Urge Congress to help make them available

Urge Congress to reauthorize the program that provides free and low-cost breast and cervical cancer screenings to people who might not otherwise be able to afford them. 

Latest Updates

January 21, 2026
Maryland

With the imminent release of Governor Wes Moore’s executive budget proposal, cancer survivors are increasingly anxious about what this budget will mean for three key line items. They are hopeful that the state restores funding for the tobacco control program and maintains its investments in the Breast and Cervical Cancer Diagnosis and Treatment Program (BCCDT) as well as ongoing research at the University of Maryland Medical System Stewart Greenebaum Cancer Center and the Johns Hopkins University Sidney Kimmel Cancer Center. Their message to the governor and General Assembly: cancer prevention and early detection and the research behind modern screening, treatment and prevention tools are critical in the fight against cancer.

January 20, 2026
Pennsylvania

At the start of Pennsylvania’s 2026 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) is calling on lawmakers to seize opportunities to ease the burden of cancer. Advocates are urging state leaders to prioritize affordability and ensure that cost is not a barrier to Pennsylvanians’ ability to prevent, detect, treat and survive cancer.

January 15, 2026
Washington

OLYMPIA, Wash. – As Washington residents face soaring health insurance costs and hundreds of thousands at risk of losing life-saving coverage, volunteer advocates of the American Cancer Society Cancer Action Network will ask lawmakers on Wednesday to use the 2026 legislative session to preserve access to Medicaid and Medicaid expansion.

January 12, 2026
New York

As New York State’s 2026 legislative session begins and Governor Hochul prepares to deliver her State of the State address, the American Cancer Society Cancer Action Network (ACS CAN) is calling on lawmakers to seize both immediate and long-term opportunities to ease the burden of cancer. Advocates are urging state leaders to prioritize affordability and ensure continued progress in the fight against this disease.

Breast and Cervical Cancer Resources

ACS CAN supports the Access to Breast Cancer Diagnosis Act to increase access to no cost breast cancer screening, including all diagnostic and supplemental tests.

Breast cancer is the most common cancer diagnosed in women in the U.S. Although there has been substantial progress in reducing breast cancer mortality in the US over the past several decades, there are persistent disparities, especially among Black women. Additionally, breast cancer incidence is increasing, with the steepest trends among young women under 50. In 2025, an estimated 316,950 women in the U.S. will be diagnosed with invasive breast cancer with an additional 59,080 cases of ductal carcinoma in situ (DCIS) in women, and 42,680 will die from the disease. 

Early detection of breast and cervical cancer through screening can improve survival and reduce mortality by finding cancer at an early stage when treatment is more effective and less expensive. To save lives and reduce health care spending, the Centers for Disease Control and Prevention’s (CDC) National Breast and Cervical Cancer Early Detection Program (NBCCEDP) is highly effective at detecting and treating breast and cervical cancer in people who may otherwise not be screened.